Distinct MDM2 and P14ARF Expression and Centrosome Amplification in Well-Differentiated Liposarcomas

Genes Chromosomes and Cancer

Volumn 39, Issue 2, 2004, Pages 99-109

  Perucca Lostanlen, D ^a   Rostagno, P ^b   Grosgeorge, J ^a   Marcie S ^b   Gaudray, P ^a   Turc Carel, C ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; PROTEIN MDM2; PROTEIN P14ARF; PROTEIN P53;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL TYPE; CENTROSOME; CHROMOSOME 12Q; CONTROLLED STUDY; DNA CONTENT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LIPOSARCOMA; MARKER CHROMOSOME; MITOSIS; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROPERITONEAL SARCOMA; RING CHROMOSOME; SOFT TISSUE SARCOMA; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CENTROSOME; CHROMOSOME ABERRATIONS; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KARYOTYPING; LIPOMA; LIPOSARCOMA; MIDDLE AGED; MITOSIS; MITOTIC SPINDLE APPARATUS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RETROPERITONEAL NEOPLASMS; SOFT TISSUE NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0346096792     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10303     Document Type: Article

References (49)

1. Bartel F, Taubert H, Harris LC. 2002. Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell 2:9-15.
2. Berner JM, Forus A, Elkahloun A, Mekzer PS, Fodstad O, Myklebost O. 1996. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer 17:254-259.
3. Bobinnec Y, Khodjakov A, Mir LM, Rieder CL, Eddé B, Bornens M. 1998. Centriole disassembly in vivo and its effect on centrosome structure and function in vertebrate cells. J Cell Biol 143: 1575-1589.
4. Bornens M. 2002. Centrosome composition and microtubule anchoring mechanisms. Curr Opin Cell Biol 14:25-34.
5. Brinkley BR. 2001. Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11:18-21.
6. Caroll PE, Okuda M, Horn HH, Biddinger P, Stambrook PJ, Gleich LL, Li Y-Q, Taparapore P, Fukasawa K. 1999. Centrosome hyperamplification in human cancer: chromosome instability induced by p53 and/or MDM2 overexpression. Oncogene 18:1935-1944.
7. Clarks PA, Llanos S, Peters G. 2002. Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2. Oncogene 21:4498-4507.
8. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ. 1994. Molecular abnormalities of MDM2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54:794-799.
9. Doxsey SJ. 2001. Centrosomes as command centres for cellular control. Nat Cell Biol 3:105-108.
10. Doxsey SJ. 2002. Duplicating dangerously: linking centrosome duplication and aneuploidy. Mol Cell 10:439-440.
11. Duensing S, Münger K. 2001. Centrosome abnormalities, genomic instability and carcinogenic progression. Biochim Biophys Acta 1471:81-88.
12. Duesberg P. 1999. Are centrosomes of aneuploidy the key to cancer? Science 25:2091-2092.
13. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher JM, Bron L, Benhattar J, Tadas M, Van Meir EG, Estreicher A, Iggo RD. 1995. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 92:3963-3967.
14. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. 1996. Abnormal centrosome amplification in the absence of p53. Science 271:1744-1747.
15. Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A, Auer G, Ried T. 2000. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines and correlates with numerical aberrations. Genes Chromosomes Cancer 27:183-190.
16. Hall PA, Lane DP. 1997. MDM2-arbitrer of p53's destruction. Trends Biochem Sci 22:372-374.
17. Heim S, Mandahl N, Mitelman F. 1988. Genetic convergence and divergence in tumor progression. Cancer Res 48:5911-5916.
18. Kubbatat MHG, Jones SN, Vousden KH. 1997. Regulation of p53 stability by MDM2. Nature 287:299-303.
19. Kuo KK, Sheen PC, Chang SC, Chen JS, Lee KT, Cham CM. 2000. Centrosome abnormalities in human carcinomas of the gallbladder and intrahepatic bile ducts. Hepatology 31:59-64.
20. Lajoie-Mazenc I, Tollon Y, Detraves C, Julian M, Moisand A, Gueth-Hallonet C, Debec A, Salles-Passador I, Puget A, Mazarguil H, Raynaud-Messina B, Wright M. 1994. Recruitment of antigenic gamma-tubulin during mitosis in animal cells: presence of gamma-tubulin in the mitotic spindle. J Cell Sci 107:2825-2837.
21. Langle BMH. 2002. Integration of the centrosome in cell cycle control, stress response and signal transduction pathways. Curr Opin Cell Biol 14:35-43.
22. Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL. 1998. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc Natl Acad Sci USA 95: 2950-2955.
23. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL. 2002. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Sci USA 99:1978-1983.
24. Mayer F, Stoop H, Sen S, Bokemeyer C, Oosterhuis JW, Looijenga LH. 2003. Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes. Oncogene 22:3859-3866.
25. Momand J, Jung D, Wilczynski S, Niland J. 1998. The MDM2 gene amplification database. Nucleic Acids Res 26:3453-3459.
26. Montgomery K, Lee E, Miller A, Lau S, Shim C, Decker J, Chlu D, Emerling S, Sekhon M, Kim R, Lenz J, Han J, Ioshikhes I, Renault B, Marondel Y, Yoon SJK, Murty VVVS, Sherer S, Yonescu R, Kirsch IR, Ried T, McPherson J, Gibbs R, Kucherlapati R. 2001. A high-resolution map of human chromosome 12. Nature 409:945-946.
27. Nigg EA. 2002. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2:815-825.
28. Nowell PC. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
29. Oliner JD, Kinzler KW, Meltzer PS, Georges DL, Vogelstein B. 1992. Amplification of a gene encoding a p53 associated protein in human sarcomas. Nature 358:80-83.
30. Oliner JD, Pietenpol JA, Thiagalingam S, Gvuris J, Kinzler KW, Vogelstein B. 1993. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature 362:857-860.
31. Pedeutour F, Suijkerbuijk RF, Forus A, Van Gaal J, Van de Klundert W, Coindre JM, Nicolo G, Collin F, Van Haelst U, Huffermann K, Turc-Carel C. 1994. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod market chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer 10:85-94.
32. Pedeutour F, Forus A, Coindre JM, Berner JM, Nicolo G, Michiels F, Terrier P, Ranchere-Vince D, Collin F, Myklebost O, Turc-Carel C. 1999. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24:30-41.
33. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ. 1998. Centrosome defects and genetic instability in malignant tumors. Cancer Res 58:3974-3985.
34. Pihan GA, Purohit A, Wallace J, Malhtra R, Liotta L, Doxsey SJ. 2001. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 61:2212-2219.
35. Pihan GA, Wallace J, Zhou Y, Doxsey SJ. 2003. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 63:1398-1404.
36. Pilotti S, Della Torre G, Lavarino C, Di Palma S, Sozzi G, Minoletti F, Rao S, Pasquini G., Azzarelli A, Rilke F, Pierotti MA. 1997. Distinct MDM2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol 181:14-24.
37. Pilotti S, Della Torre G, Lavarino C, Sozzi G, Minoletti F, Vergani B, Azzarelli A, Rilke F, Pierotti MA. 1998. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22. J Pathol 185:188-190.
38. Pilotti S, Della Torre G, Mezzelani A, Tamborini E, Azzarelli A, Sozzi G, Pierotti MA. 2000. The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma. Br J Cancer 82:1271-1275.
39. Rostagno P, Birtwisle I, Ettore F, Courdi A, Gioanni J, Namer M, Caldani C. 1994. Immunohistochemical determination of nuclear antigens by colour image analysis: application for labelling index, estrogen and progesterone receptor status in breast cancer. Anal Cell Pathol 7:275-87.
40. Ruas M, Peters G. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1378:115-177.
41. Sandberg AA, Turc-Carel C. 1987. The cytogenetics of solid tumors. Relation to diagnosis, classification and pathology. Cancer 59:387-395.
42. Sato N, Mizumoto K, Nakamura M, Maehara N, Minamishima YA, Nishio S, Nagai E, Tanaka M. 2001. Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. Cancer Genet Cytogenet 126:13-19.
43. Sherr CH, Weber JD. 2000. The ARF/p53 pathway. Current Opin Genet Dev 10:94-99.
44. Sigalas I, Calvert AH, Anderson JJ, Neal DE, Lunec J. 1996. Alternatively spliced MDM2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nature Med 2:912-917.
45. Tamborini E, Della Torre G, Lavarino C, Azzarelli A, Carpinelli P, Pierotti M, Pilotti S. 2001. Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas. Int J Cancer 92:790-796.
46. Vindelov LL, Christensen ID, Nissen NI. 1983. A detergent-trypsin method for the preparation of nuclei for flow cytometry DNA analysis. Cytometry 3:323-327.
47. Weber RG, Bridger JM, Benner A, Weisenberger D, Eheman V, Reifenberg G, Lichter P. 1998. Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations. Cytogenet Cell Genet 83:266-269.
48. Weiss SW, Goldblum JR. 2001. Liposarcomas. In: Enzinger FM, Weiss SW. Soft tissue tumors. 4th ed. St. Louis, MO: CV Mosby. p 641-693.
49. Wong C, Stearns T. 2003. Centrosome number is controlled by a centrosome-intrinsic block to reduplication. Nat Cell Biol 5:539-544.